Immunomodulators are to be prescribed to tuberculous patients in accordance with clinical and immunologic indices for 2 months. Taking into account that levamisol in dose 100 mg/24 hours is well tolerated by the patients and is as efficient as in the dose 150 mg/24 hours it is recommended to use this agent in dose 100 mg/24 hours three times a week. As it became evident from the clinical-roentgenologic, bacteriologic and immunologic data diuciphon is better tolerated by the patients and more efficient than levamisol.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mg/24 hours
12
dose 100
8
100 mg/24
8
tolerated patients
8
patients efficient
8
efficiency chemotherapy
4
chemotherapy immunomodulators
4
patients
4
immunomodulators patients
4
patients destructive
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!